Endo International PLC (NASDAQ:ENDP) (TSE:ENL)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $3.82, but opened at $3.96. Endo International shares last traded at $4.15, with a volume of 69,769 shares.
A number of research firms recently commented on ENDP. Canaccord Genuity reaffirmed a “hold” rating and issued a GBX 365 ($4.77) price target on shares of Crest Nicholson in a report on Wednesday, May 15th. Gabelli reaffirmed a “hold” rating on shares of Endo International in a report on Wednesday, March 27th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $130.00 price target (up previously from $116.00) on shares of Zoetis in a report on Wednesday, June 12th. SunTrust Banks started coverage on shares of Zoetis in a report on Tuesday, March 19th. They issued a “hold” rating and a $100.00 price target on the stock. Finally, Barclays reissued a “hold” rating on shares of Bank of Montreal in a report on Tuesday, June 11th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have assigned a buy rating to the company’s stock. Endo International currently has an average rating of “Hold” and a consensus target price of $11.57.
The stock has a market capitalization of $927.35 million, a PE ratio of 1.49 and a beta of 1.15. The company has a fifty day simple moving average of $4.56.
Endo International (NASDAQ:ENDP) (TSE:ENL) last released its quarterly earnings results on Thursday, May 9th. The company reported $0.53 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.11. The firm had revenue of $720.00 million for the quarter, compared to analysts’ expectations of $692.31 million. Endo International had a negative net margin of 18.35% and a negative return on equity of 199.18%. The business’s quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.67 earnings per share. On average, sell-side analysts expect that Endo International PLC will post 2.17 earnings per share for the current year.
In other news, Director Roger H. Kimmel sold 34,951 shares of the company’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $3.93, for a total value of $137,357.43. Following the transaction, the director now owns 148,309 shares of the company’s stock, valued at $582,854.37. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 0.80% of the company’s stock.
Large investors have recently made changes to their positions in the stock. Signition LP purchased a new position in Endo International in the first quarter worth $139,000. Factorial Partners LLC purchased a new position in Endo International in the first quarter worth $193,000. First Quadrant L P CA grew its position in Endo International by 94.7% in the first quarter. First Quadrant L P CA now owns 24,513 shares of the company’s stock worth $197,000 after acquiring an additional 11,926 shares in the last quarter. Neuburgh Advisers LLC grew its position in Endo International by 13.9% in the fourth quarter. Neuburgh Advisers LLC now owns 24,860 shares of the company’s stock worth $181,000 after acquiring an additional 3,036 shares in the last quarter. Finally, Flinton Capital Management LLC grew its position in Endo International by 13.9% in the fourth quarter. Flinton Capital Management LLC now owns 38,420 shares of the company’s stock worth $280,000 after acquiring an additional 4,692 shares in the last quarter. Institutional investors own 93.59% of the company’s stock.
About Endo International (NASDAQ:ENDP)
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Read More: What is the Ex-Dividend Date in Investing?
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.